Detalhe da pesquisa
1.
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356459
2.
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice.
Haematologica
; 108(5): 1322-1334, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655430
3.
Noncanonical Functions of Antibodies.
Trends Immunol
; 41(5): 379-393, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273170
4.
Hyperoxidized Species of Heme Have a Potent Capacity to Induce Autoreactivity of Human IgG Antibodies.
Int J Mol Sci
; 24(4)2023 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36834827
5.
Inhibitors-Recent insights.
Haemophilia
; 27 Suppl 3: 28-36, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608138
6.
Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock.
Cell Immunol
; 347: 104020, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767118
7.
Stimulation with FITC-labeled antigens confers B cells with regulatory properties.
Cell Immunol
; 355: 104151, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615414
8.
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA.
Haematologica
; 105(4): 1129-1137, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289204
9.
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
Haemophilia
; 26(6): 958-965, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885562
10.
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
Haematologica
; 104(2): 236-244, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514798
11.
Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A.
Haematologica
; 104(5): 1046-1054, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545924
12.
Thermodynamic stability contributes to immunoglobulin specificity.
Trends Biochem Sci
; 39(5): 221-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24685657
13.
Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A.
Cell Immunol
; 325: 64-68, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395036
14.
Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors.
Cell Immunol
; 331: 22-29, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29751951
15.
Inhibitor Formation in Congenital Hemophilia A: an Immunological Perspective.
Semin Thromb Hemost
; 44(6): 517-530, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29864775
16.
Complement C3 is a novel modulator of the anti-factor VIII immune response.
Haematologica
; 103(2): 351-360, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146705
17.
Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.
J Immunol
; 196(10): 4075-81, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067006
18.
A molecular jewel for hemophilia A treatment.
Blood
; 135(17): 1417-1419, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32324867
19.
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
Haematologica
; 102(2): 271-281, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758819
20.
The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.
Haematologica
; 102(11): 1833-1841, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751567